Response to: Prognosis of metastatic bone cancer and myeloma patients and long‑term risk of medication‑related osteonecrosis of the jaw (MRONJ): some critical points

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Supportive care in cancer 2022-12, Vol.30 (12), p.9693-9695
Hauptverfasser:	Hata, Hironobu, Imamachi, Kenji, Ueda, Michihiro, Matsuzaka, Masashi, Hiraga, Hiroaki, Osanai, Toshihisa, Harabayashi, Toru, Fujimoto, Katsuya, Oizumi, Satoshi, Takahashi, Masato, Yoshikawa, Kazuhito, Sato, Jun, Yamazaki, Yutaka, Kitagawa, Yoshimasa
Format:	Artikel
Sprache:	eng
Schlagworte:	Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology Bone Density Conservation Agents - adverse effects Bone Neoplasms - drug therapy Bone Neoplasms - secondary Correspondence Diphosphonates Humans Medicine Medicine & Public Health Multiple Myeloma - drug therapy Nursing Nursing Research Oncology Osteonecrosis - chemically induced Pain Medicine Prognosis Rehabilitation Medicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!